276 related articles for article (PubMed ID: 16205112)
1. Towards the human cancer epigenome: a first draft of histone modifications.
Fraga MF; Esteller M
Cell Cycle; 2005 Oct; 4(10):1377-81. PubMed ID: 16205112
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
3. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.
Fraga MF; Ballestar E; Villar-Garea A; Boix-Chornet M; Espada J; Schotta G; Bonaldi T; Haydon C; Ropero S; Petrie K; Iyer NG; Pérez-Rosado A; Calvo E; Lopez JA; Cano A; Calasanz MJ; Colomer D; Piris MA; Ahn N; Imhof A; Caldas C; Jenuwein T; Esteller M
Nat Genet; 2005 Apr; 37(4):391-400. PubMed ID: 15765097
[TBL] [Abstract][Full Text] [Related]
4. The necessity of a human epigenome project.
Esteller M
Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
[TBL] [Abstract][Full Text] [Related]
5. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.
Kapoor-Vazirani P; Kagey JD; Powell DR; Vertino PM
Cancer Res; 2008 Aug; 68(16):6810-21. PubMed ID: 18701507
[TBL] [Abstract][Full Text] [Related]
6. Histone acetylation modifiers in the pathogenesis of malignant disease.
Mahlknecht U; Hoelzer D
Mol Med; 2000 Aug; 6(8):623-44. PubMed ID: 11055583
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
8. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain.
Grandjean V; O'Neill L; Sado T; Turner B; Ferguson-Smith A
FEBS Lett; 2001 Jan; 488(3):165-9. PubMed ID: 11163765
[TBL] [Abstract][Full Text] [Related]
9. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
10. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer.
Deng G; Nguyen A; Tanaka H; Matsuzaki K; Bell I; Mehta KR; Terdiman JP; Waldman FM; Kakar S; Gum J; Crawley S; Sleisenger MH; Kim YS
Int J Cancer; 2006 Jun; 118(12):2999-3005. PubMed ID: 16425274
[TBL] [Abstract][Full Text] [Related]
11. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
12. The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications.
Ballestar E; Esteller M
Prog Mol Subcell Biol; 2005; 38():169-81. PubMed ID: 15881895
[TBL] [Abstract][Full Text] [Related]
13. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
14. Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
Kedhari Sundaram M; Hussain A; Haque S; Raina R; Afroze N
J Cell Biochem; 2019 Oct; 120(10):18357-18369. PubMed ID: 31172592
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
16. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
18. Emerging connections between DNA methylation and histone acetylation.
Dobosy JR; Selker EU
Cell Mol Life Sci; 2001 May; 58(5-6):721-7. PubMed ID: 11437233
[TBL] [Abstract][Full Text] [Related]
19. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
20. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats.
Pogribny IP; Ross SA; Tryndyak VP; Pogribna M; Poirier LA; Karpinets TV
Carcinogenesis; 2006 Jun; 27(6):1180-6. PubMed ID: 16497704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
